We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Works to Improve ANDA Processes Ahead of Fall Deadline
FDA Works to Improve ANDA Processes Ahead of Fall Deadline
SAN DIEGO — The FDA is racing to beat a fall deadline to release a string of new guidances for generics makers that it hopes will head off a potential torrent of rejected submissions.